9/16 cases with chronic persistent hepatitis (CPH), and 14/33 patients with acute viral hepatitis (AVH), 2/10 patients with 'inactive' cirrhosis of the liver (Ci), 4114 patients with alcohol induced liver disease (ALD), 1/7 patients with miscellaneous liver diseases (MLD), and in 6/58 patients with primary non-hepatic autoimmune disease (PNHA). Frequencies of anti-LSP did not depend on HBsAg status. Anti-rabbit LSP was detected in only 9 % of patients with AVH as compared with 42% for anti-human LSP. No such difference was observed in the other groups of patients. Anti-HKP was found in 6/62 patients with CALD, 1/7 patients with MLD, and 2/58 patients with PNHA; no anti-HKP occurred in patients with CPH, AVH, ALD, and Ci. The frequency ofanti-LSP was not correlated with the presence of non-organ-specific autoantibodies in patients with CALD; furthermore, no correlation with sex-distribution, age, gammaglobulin levels, and SGOT occurred in this group of patients. No correlation existed between anti-LSP and liver membrane autoantibodies detected by indirect immunofluorescence on isolated rabbit hepatocytes (LMA). The reported data show that naturally occurring anti-LSP, characteristic for acute and chronic inflammatory liver diseases, are mostly directed against organ-specific determinants ofthe LSP complex. It Fig. 2 ). Anti-LSP was also found in 4/14 patients (28%) with alcohol-induced liver diseases. These four anti-LSP positive cases all showed periportal inflammation on liver biopsy. Another two patients with periportal inflammation were anti-LSP negative. The rest, eight cases, were anti-LSP negative and had no periportal inflamma- (Fig. 3) . One of 10 patients with Crohn's disease and one of Recently we reported on the detection of speciesspecific and non-species-specific determinants of the LSP-complex.1" These determinants could be demonstrated by a sheep anti-human LSP serum and by sera from rabbits with experimentally induced CAH. Therefore rabbit LSP was included as test antigen in this study to evaluate whether speciesspecific and/or non-species-specific determinants of LSP are targets in human liver diseases. The highest incidence of anti-rabbit LSP was observed in CAH, CPH, and Ci, whereas in AVH only 9 % were positive compared with 42% for anti-human LSP. This is an interesting observation, as autoimmunity to LSP was found to be transient in uncomplicated AVH.56 We suggest that humoral immunity to non-species-specific determinants of LSP reflect self-perpetuating autoimmunity, whereas antibodies to the species-specific determinant of LSP reflect a transient state of auto-immunity. This observation needs further clarification.
The present preparation of LSP is far from being a pure antigen, and additional purification seems necessary. It has to be evaluated whether organspecific, non-organ-specific, species-specific, and non-species-specific determinants are located on a single molecule, on different molecules, or whether we are dealing with a real antigen complex.
Kakumu et al.6 reported a lack of absorption of anti-LSP by kidney proteins in five sera. Investigations on the organ-specificity of anti-LSP were not reported by Jensen et al.5 Only a few sera reacted with the LSP equivalent prepared from human kidneys (HKP), whereas most of the sera positive for anti-HKP were positive for anti-LSP as well; one patient with SLE had antibodies only to HKP (Fig. 2) . These data show that naturally occurring autoantibodies to LSP are mostly directed against organ-specific determinants of LSP and not against non-organ-specific components of the LSP complex, as could be concluded from studies done by Behrens and Paronetto. ' 
